333 Mercy Avenue, Merced, CA, 95340 · (209) 564-5000
Beds
186
FY 2025
Star rating
3 of 5
Patient survey: 3 of 5
Net patient revenue
$431.5M
FY 2025
Net income
$82.2M
Patient care margin 8.1%
Discharges
10,960
Occupancy 79.0%
Clinicians
361
From the hospital's yearly cost reports (fiscal years as the hospital reports them)
Locations are shown at the center of the ZIP code.
US dollars as reported. Patient care margin = net patient revenue minus operating expenses, before other income such as grants, donations and investments.
| Fiscal year | Net patient revenue | Operating expenses | Patient care margin | Net income | Discharges | Uncompensated care | Medicare days | Medicaid days |
|---|---|---|---|---|---|---|---|---|
| 2025 | $431.5M | $396.4M | 8.1% | $82.2M | 10,960 | $20.1M | 31.2% | 4.2% |
Official hospital quality measures with the national median across hospitals. For ratios, 1.00 means as many cases as expected.
| Death rate for COPD patients | 7.7% | US median 8.5% |
| Death rate for heart attack patients | 11.7% | US median 11.8% |
| Death rate for heart failure patients | 11.3% | US median 11% |
| Hospital-wide death rate within 30 days | 3.6% | US median 3.9% |
| Death rate for pneumonia patients | 17.5% | US median 15.2% |
| Death rate for stroke patients | 11% | US median 11.6% |
Medicare clinicians who list this hospital, by specialty
Inpatient stays by diagnosis related group (DRG), 2024
Official US government data: hospital records, ownership records, yearly cost reports and quality measures, linked by the hospital's CCN and NPI. Financials are for fiscal years as reported by the hospital.
Medicare clinicians who work here
| 2024 | $440.9M | $396.1M | 10.2% | $57.4M | 10,468 | $21.5M | 30.6% | 2.7% |
| 2023 | $385.2M | $372.4M | 3.3% | $33.3M | 10,378 | $18.7M | 35.6% | 3.6% |
| 2022 | $360.4M | $352.3M | 2.3% | $20.6M | 11,029 | $13.6M | 34.1% | 5.4% |
| 2021 | $345.0M | $335.0M | 2.9% | $33.5M | 10,786 | $8.4M | 34.2% | 7.6% |
| 2020 | $321.0M | $317.5M | 1.1% | $101.5M | 10,879 | $10.7M | 38.5% | 8.0% |
| Readmission rate for COPD | 19.9% | US median 19.8% |
| Readmission rate after a heart attack | 14% | US median 14.4% |
| Readmission rate for heart failure | 21.5% | US median 21.3% |
| Readmission rate for pneumonia | 18.8% | US median 17.2% |
| Serious complications (patient safety composite) | 0.74 | US median 0.96 |
| C. diff intestinal infections (ratio to expected) | 0.36 | US median 0.28 · better |
| Central line bloodstream infections (ratio to expected) | 0.17 | US median 0.48 · better |
| Surgical site infections after colon surgery (ratio to expected) | 0.76 | US median 0.72 |
| MRSA bloodstream infections (ratio to expected) | 0.00 | US median 0.60 |
| Catheter urinary tract infections (ratio to expected) | 0.00 | US median 0.40 · better |
| Doctors always communicated well | 75% | US median 79% |
| Nurses always communicated well | 78% | US median 80% |
| Patient survey summary star rating | 3 of 5 | US median 3 of 5 |
| Area around the room always quiet at night | 49% | US median 59% |
| Patients who rated the hospital 9 or 10 out of 10 | 64% | US median 72% |
| Room and bathroom always clean | 73% | US median 73% |
| Patients who would definitely recommend the hospital | 59% | US median 71% |
| Patients who left the emergency department before being seen | 2% | US median 1% |
| Median time in the emergency department before leaving (minutes) | 224 min | US median 148 min |
| Patients prescribed 2 or more opioids or opioids with benzodiazepines at discharge | 9% | US median 15% |
| Patients who got appropriate care for severe sepsis and septic shock | 76% | US median 65% |
| Healthcare workers given the flu vaccine | 72% | US median 79% |
| Stroke patients who got a brain scan within 45 minutes of arrival | 76% | US median 74% |
| 79 |
| $97,644.35 |
| $9,896.70 |
| $7,681.44 |
| DRG 177 RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH MCC | 72 | $126,039.88 | $16,852.50 | $12,667.88 |
| DRG 698 OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH MCC | 68 | $111,242.85 | $16,068.13 | $13,076.55 |
| DRG 193 SIMPLE PNEUMONIA AND PLEURISY WITH MCC | 61 | $92,481.82 | $13,192.92 | $9,867.73 |
| DRG 640 MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM, FLUIDS AND ELECTROLYTES WITH MCC | 48 | $107,559.67 | $13,319.75 | $10,642.23 |
| DRG 690 KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MCC | 44 | $67,802.82 | $7,643.68 | $5,985.69 |
| DRG 190 CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MCC | 43 | $80,041.12 | $10,843.00 | $8,466.56 |
| DRG 682 RENAL FAILURE WITH MCC | 42 | $104,926.02 | $14,518.12 | $11,457.18 |
| DRG 853 INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURES WITH MCC | 40 | $334,982.50 | $50,673.35 | $40,556.82 |
| DRG 638 DIABETES WITH CC | 38 | $78,662.16 | $8,529.61 | $6,926.41 |
| DRG 603 CELLULITIS WITHOUT MCC | 36 | $70,967.89 | $8,140.89 | $6,446.25 |
| DRG 189 PULMONARY EDEMA AND RESPIRATORY FAILURE | 36 | $99,920.11 | $11,006.97 | $9,973.97 |
| DRG 065 INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH CC OR TPA IN 24 HOURS | 36 | $99,597.50 | $9,265.25 | $7,474.08 |
Hospital outpatient services by payment group (APC), 2024
| Service group | Services | Patients | Medicare pays per service | All hospitals |
|---|---|---|---|---|
| APC 8011 Comprehensive Observation Services | 308 | 294 | $2,662.76 | $2,090.36 |
| APC 5115 Level 5 Musculoskeletal Procedures | 150 | 142 | $14,311.24 | $10,771.69 |
| APC 5072 Level 2 Excision/ Biopsy/ Incision and Drainage | 100 | 98 | $1,555.88 | $1,219.56 |
| APC 5191 Level 1 Endovascular Procedures | 99 | 98 | $2,814.55 | $2,207.96 |
| APC 5361 Level 1 Laparoscopy and Related Services | 86 | 82 | $5,649.00 | $4,357.80 |
| APC 5114 Level 4 Musculoskeletal Procedures | 74 | 74 | $7,048.50 | $5,338.75 |
| APC 5375 Level 5 Urology and Related Services | 57 | 57 | $4,886.75 | $3,917.51 |
| APC 5113 Level 3 Musculoskeletal Procedures | 54 | 53 | $3,125.18 | $2,373.24 |
| APC 5112 Level 2 Musculoskeletal Procedures | 46 | 46 | $1,571.72 | $1,196.16 |
| APC 5183 Level 3 Vascular Procedures | 43 | 42 | $3,122.31 | $2,405.01 |
| APC 5116 Level 6 Musculoskeletal Procedures | 36 | 35 | $20,733.66 | $15,762.73 |
| APC 5431 Level 1 Nerve Procedures | 36 | 32 | $1,883.26 | $1,406.61 |
Reported payments to this teaching hospital
| Company | Payments | Amount |
|---|---|---|
| Endotronix, Inc. | 1 | $57K |
| Baxter Healthcare BAX | 1 | $364 |
Official US government data on Original Medicare hospital stays and outpatient services; groups with fewer than 11 cases are not published. Payments are those drug and device companies must report.
Mercy Medical Center is a nonprofit short-term acute care hospital in Merced, CA with 186 beds, part of CommonSpirit Health and a 3-star overall rating.
Mercy Medical Center in Merced, CA has 186 beds (fiscal year 2025 cost report). It discharged 10,960 inpatients that year, with 79.0% of its beds in use on average.
In fiscal year 2025 (ending 2025-06-30), Mercy Medical Center reported net patient revenue of $431.5M and operating expenses of $396.4M, a margin on patient care of 8.1%. After other income and expenses its net income was $82.2M (17.2% of revenue), so it made a profit that year.
Mercy Medical Center is part of CommonSpirit Health, a health system with 129 hospitals based in San Francisco, CA. It is a nonprofit hospital.
Mercy Medical Center has an overall rating of 3 out of 5 stars in the official hospital quality ratings. Patients rate it 3 out of 5 stars in the patient survey. 0 death rate measures are better and 1 worse than the national rate.
Yes, Mercy Medical Center provides emergency services.
361 Medicare clinicians list Mercy Medical Center as a hospital they work at, most often in Family Practice, Internal Medicine, Diagnostic Radiology.
In 2024, Mercy Medical Center had 1,959 Medicare inpatient stays in 50 diagnosis groups. The most common was DRG 871 (septicemia or severe sepsis without mv >96 hours with mcc) with 431 stays; Medicare paid $19,804.47 per stay on average, compared with $15,524.21 across all hospitals.
In 2025, companies reported $57K in payments to Mercy Medical Center as a teaching hospital ($364 general and $57K for research) from 2 companies.